Clinical trial
A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of Single-use Ring-shaped Pulmonary Artery Radiofrequency (RF) Ablation Catheter and Pulmonary Artery RF Ablation Generator for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
NCT05824923 is registered in ClinicalTrials.gov with Pulnovo Medical (Wuxi) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of Single-use Ring-shaped Pulmonary Artery Radiofrequency (RF) Ablation Catheter and Pulmonary Artery RF Ablation Generator for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
- Lead sponsor
- Pulnovo Medical (Wuxi) Co., Ltd.
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- August 14, 2023
- Completion date
- February 28, 2027
- Enrollment
- 264 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, heart failure, heart failure with mid range ejection fraction, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, hypertension, pulmonary hypertension, vascular diseases